ABSTRACT

Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) is one of the biggest health challenges across the globe ever since its eruption in late 2019. Novelty, contagiousness, and lethality of the virus demand the expedited production of potential therapeutic agents and strategies against it. Since no COVID-19 specific drug is available yet, it persists a crucial challenge to determine what therapeutic strategies should be adopted for the treatment of coronavirus patients. Until there is any specific drug for COVID-19, repurposing of the existing FDA-approved drugs is the most suitable approach to treat the severely ill patients of COVID-19. This review will summarize the existing antiviral drugs being repurposed and probed for their potential as effective anti-COVID-19 drugs all over the world.

Key Words: Antiviral Drugs, Coronavirus, Drug Repurposing, Drug Repositioning.

How to cite this: Wahedi HM, Amraiz D. Repurposing of Antiviral Drugs for Covid-19 Therapy. Life and Science. 2020; 1(suppl): 22-31.  doi: http://doi.org/10.37185/LnS.1.1.151